Literature DB >> 11929256

Synthesis, properties, and reactivity of cocaine benzoylthio ester possessing the cocaine absolute configuration.

Shigeki Isomura1, Timothy Z Hoffman, Peter Wirsching, Kim D Janda.   

Abstract

One aspect of immunopharmacotherapy for cocaine abuse involves the use of a catalytic monoclonal antibody (mAb) to degrade cocaine via hydrolysis of the benzoate ester. A cocaine benzoylthio ester analogue provides a means to implement high-throughput selection strategies to potentially isolate mAbs with high activity. The required analogue was synthesized starting from (-)-cocaine hydrochloride and possessed the cocaine absolute configuration. Key points in the preparation were the introduction of the sulfur atom at C-3 via a bromomagnesium thiolate addition to the exo face of anhydroecgonine, separation of C-2 diastereomers, recycling of a C-2 thio ester byproduct, and formation of the necessary C-2 methyl and C-3 benzoylthio esters. Effects resulting from the lower electronegativity and greater hydrophobicity of sulfur compared to oxygen were observed. These characteristics could result in interesting drug properties. Furthermore, the analogue was found to be a substrate for catalytic mAbs that hydrolyze cocaine as monitored by HPLC and also spectrophotometry by coupling cleavage of the benzoylthio ester to the disulfide exchange with Ellman's reagent. Screening antibody libraries with the new cocaine analogue using the spectroscopic assay provides an avenue for the high-throughput identification of catalysts that efficiently breakdown cocaine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929256     DOI: 10.1021/ja012376y

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  7 in total

Review 1.  Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity.

Authors:  Charles W Schindler; Steven R Goldberg
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  In silico experiments of single-chain antibody fragment against drugs of abuse.

Authors:  Guodong Hu; L Y Chen
Journal:  Biophys Chem       Date:  2010-10-18       Impact factor: 2.352

3.  Probing active cocaine vaccination performance through catalytic and noncatalytic hapten design.

Authors:  Xiaoqing Cai; Timothy Whitfield; Mark S Hixon; Yanabel Grant; George F Koob; Kim D Janda
Journal:  J Med Chem       Date:  2013-04-29       Impact factor: 7.446

Review 4.  Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy.

Authors:  Tobin J Dickerson; Kim D Janda
Journal:  AAPS J       Date:  2005-10-19       Impact factor: 4.009

5.  Identification and characterization of single chain anti-cocaine catalytic antibodies.

Authors:  Kathleen M McKenzie; Jenny M Mee; Claude J Rogers; Mark S Hixon; Gunnar F Kaufmann; Kim D Janda
Journal:  J Mol Biol       Date:  2006-11-03       Impact factor: 5.469

6.  Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase.

Authors:  Chang-Guo Zhan; Fang Zheng; Donald W Landry
Journal:  J Am Chem Soc       Date:  2003-03-05       Impact factor: 15.419

7.  Treating cocaine addiction with viruses.

Authors:  M Rocio A Carrera; Gunnar F Kaufmann; Jenny M Mee; Michael M Meijler; George F Koob; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.